What You Should Know:
– AccessHope, a company revolutionizing how cancer patients receive cutting-edge treatment plans secures $33M in a Series B funding round led by City of Hope, a prominent cancer research and treatment organization.
– The company plans to use the investment to fuel AccessHope’s next phase of growth as a standalone company.
New CEO Bradley Kreick Takes the Helm
To spearhead this growth trajectory, AccessHope has appointed seasoned healthcare veteran Bradley Kreick as its new CEO. Kreick boasts 30 years of experience leading companies through periods of significant growth, ideally positioned to guide AccessHope’s commercial expansion. Mark Stadler, AccessHope’s former CEO, will transition to the role of Chief Growth Officer, focusing on expanding cancer care benefits within health plans, Medicare, and government programs.
Cancer Collaboration Network
AccessHope’s success hinges on its unique collaboration with some of the nation’s leading National Cancer Institute (NCI)-Designated Comprehensive Cancer Centers, including City of Hope, Dana-Farber Cancer Institute, and Johns Hopkins Medicine. Through these partnerships, AccessHope grants its members access to a network of over 350 top oncologists, encompassing all cancer types and stages.
Delivering Expertise Where Patients Need It Most
AccessHope’s innovative approach empowers local oncologists by providing them with access to the latest cancer treatment insights from leading cancer centers. This collaboration ensures patients benefit from cutting-edge knowledge without leaving their local healthcare providers. AccessHope currently offers its services to over seven million members through partnerships with more than 400 employers, including over 60 Fortune 500 companies.
“AccessHope was founded with the mission of bringing cutting-edge cancer care knowledge to the places and people who need it most. Today, we are proud to serve nearly seven million members through more than 400 employers, including over 60 Fortune 500 companies and two of the nation’s largest health plans,” said Harlan Levine, M.D., chair of the AccessHope board and president, Health Innovation and Policy at City of Hope. “As demand for personalized cancer care benefits offered by AccessHope continues to grow, it is an ideal time for City of Hope to provide strategic funding and the autonomy for it to operate as a stand-alone company. This move will enable AccessHope to accelerate innovation and expand into new markets and regions, while continuing to extend access to the best cancer treatment expertise regardless of who you are and where you live.”
